Insmed To Present at Two March Conferences

Rhea-AI Summary

Insmed, a biopharmaceutical company focused on rare diseases, announced its participation in two investor conferences. The first is the Cowen 43rd Annual Healthcare Conference, set for March 8, 2023, at 12:50 p.m. ET in Boston, followed by the Barclays Global Healthcare Conference on March 15, 2023, at 4:05 p.m. ET in Miami. Both presentations will feature fireside chats and will be available for live webcast on the company's investor relations website, archived for 30 days post-event. Insmed is committed to advancing therapies for serious unmet medical needs.

BRIDGEWATER, N.J., March 1, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:

• The Cowen 43^rd Annual Healthcare Conference in Boston on Wednesday, March 8, 2023, at 12:50 p.m. ET in a fireside chat
• The Barclays Global Healthcare Conference in Miami on Wednesday, March 15, 2023, at 4:05 p.m. ET in a fireside chat

Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations 
Insmed
(718) 594-5332
eleanor.barisser@insmed.com 

Media:

Mandy Fahey 
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-two-march-conferences-301757060.html

SOURCE Insmed Incorporated

FAQ

When is Insmed's presentation at the Cowen Healthcare Conference?

Insmed will present at the Cowen 43rd Annual Healthcare Conference on March 8, 2023, at 12:50 p.m. ET in Boston.

What is the date of Insmed's presentation at the Barclays Healthcare Conference?

Insmed will present at the Barclays Global Healthcare Conference on March 15, 2023, at 4:05 p.m. ET in Miami.

How can I access the webcasts of Insmed's investor presentations?

The webcasts of Insmed's investor presentations can be accessed on their investor relations website and will be archived for 30 days after the events.

What type of company is Insmed?

Insmed is a biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases.

What is Insmed's stock ticker symbol?

Insmed's stock is listed under the ticker symbol INSM.